Literature DB >> 33825967

Corticosteroid-Sparing Drugs in Sarcoidosis: How Should We Assess Them?

Marc A Judson1.   

Abstract

Mesh：

Substances：

Year:  2021        PMID： 33825967     DOI： 10.1007/s00408-021-00439-5

Source DB:  PubMed          Journal:  Lung        ISSN： 0341-2040            Impact factor:   2.584


× No keyword cloud information.
  1 in total

1.  The prognosis of pulmonary sarcoidosis in Finland and Hokkaido, Japan. A comparative five-year study of biopsy-proven cases.

Authors:  A Pietinalho; M Ohmichi; A B Löfroos; Y Hiraga; O Selroos
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2000-06       Impact factor: 0.670
  1 in total
  2 in total

Review 1.  The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy.

Authors:  Julie H Wu; Sotonye Imadojemu; Avrom S Caplan
Journal:  Am J Clin Dermatol       Date:  2022-05-18       Impact factor: 6.233

2.  LUNG Year in Review: 2021.

Authors:  Peter V Dicpinigaitis
Journal:  Lung       Date:  2022-01-18       Impact factor: 3.777
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.